Stock Market news at lse.co.uk - RSS News Feeds

Gw Pharmaceuticals Share News (GWP)



Share News for Gw Pharmaceuticals (GWP)


Share Price: 48.25Bid: 48.25Ask: 49.50Change: -1.375 (-2.77%)Faller - Gw Pharm.
Spread: 1.25Spread as %: 2.59%Open: 51.00High: 51.00Low: 48.00Yesterday’s Close: 49.625






UPDATE 1-Spain approves GW, Almirall cannabis drug for MS

LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in its second European market, Spain, a
[28 Jul '10]

BRIEF-Almirall says MS drug Sativex approved in Spain

MADRID, July 28 (Reuters) - Almirall SA: * Says Sativex multiple sclerosis medication gets regulatory approval in Spain For more news
[28 Jul '10]

BRIEF-GW Pharma, Almirall win okay for Sativex in Spain

LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc: * Sativex receives regulatory authorisation in Spain * Launch expected 4th quarter
[28 Jul '10]

Glance-PRESS DIGEST - British Business Press - July 3

The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened t
[3 Jul '10]

Glance-PRESS DIGEST - British Business Press - July 3

The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened t
[3 Jul '10]

Glance-PRESS DIGEST - British Business Press - July 3

The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened t
[3 Jul '10]

Glance-PRESS DIGEST - British Business Press - July 3

The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened t
[3 Jul '10]

BRIEF-GW Pharmaceuticals says Sativex prescriptions being written

LONDON, July 2 (Reuters) - GW Pharmaceuticals Plc: * Since the launch of sativex, GW confirms nhs prescriptions are being written ar
[2 Jul '10]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.